The AIM-traded firm said the study, an interventional phase one clinical trial, investigated the use of the FDA-approved drug digoxin in treating metastatic breast cancer patients. It said the Parsortix system was instrumental in selecting patients for the …

… since advocated for the charity Breakthrough Breast Cancer, emphasizing the importance of regular …

… an ambassador for the charity Breakthrough Breast Cancer, stressing the importance of having …

Researchers from the University of South Australia (UNISA) have had a scientific breakthrough, uncovering early warning signs that could indicate aggressive forms of breast cancer. "There's a new receptor complex, which is an entity of its own, …

… present data on its fledgling breakthrough breast cancer therapy to the American Association …

Women with aggressive breast cancer can be effectively cured in half the time compared to current treatment, minimising harmful side effects, researchers have said. A new trial of patients suffering from HER2-positive breast cancer found survival rates …

Women with aggressive breast cancer can be be effectively cured in half the time compared to current treatment, minimising harmful side effects, researchers have said. A new trial of patients suffering from HER2-positive breast cancer found survival rates …

Currently available to up to 8,000 women in the UK, it has been described as the “closest thing to a cure”, although scientists have hinted the drug may one day be improved to form a replacement to chemotherapy for women with early-stage breast cancer. …

Two ‘breakthrough’ breast cancer drugs are to be available …

Thousands of women with previously untreatable breast cancer have been given new hope after health officials approved two new “breakthrough” drugs for NHS use. In new draft guidance, the National Institute for Health and Care Excellence (Nice) has approved …